DTP Branches and Offices
Office of the Associate Director (OAD)
DTP provides resources and services to both public and private research communities, maintains a robust infrastructure for anti-cancer drug discovery and development, and manages a large portfolio of grants pertinent to drug discovery and biochemical pharmacology. Upon request, DTP also provides advice on drug development issues regarding chemistry, manufacturing & control, pharmacology & toxicology, and IND requirements.
DTP/OAD provides planning, implementation, coordination and oversight for all DTP activities.
OAD Staff:
| Name | Position | |
|---|---|---|
| Dr. Jerry M. Collins | Associate Director | collinsje@mail.nih.gov |
| Dr. Rose Aurigemma | Deputy Associate Director | aurigemr@mail.nih.gov |
| Dr Paul G Grothaus | Chemist | grothausp@mail.nih.gov |
| Dr. Brian D. Peyser | Special Assistant to DTP Associate Director | brian.peyser@nih.gov |
| Bernadette Carter | Program Assistant | carterb2@mail.nih.gov |
About the Associate Director
Jerry M. Collins, Ph.D., is an internationally recognized pharmacologist. He has been closely associated with NCI’s drug development efforts for more than 25 years, first as an NCI intramural investigator and then as the Chief of the Pharmacokinetics Section. More…